The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Bridging the gap: metabolic and endocrine care of patients during transition
Abstract
Objective: Seamless transition of endocrine patients from the paediatric to adult setting is still suboptimal, especially in patients with complex disorders, i.e., small for gestational age, Turner or Prader–Willi syndromes; Childhood Cancer Survivors, and those with childhood-onset growth hormone deficiency. Methods: An expert panel meeting comprised of European paediatric and adult endocrinologists was convened to explore the current gaps in managing the healthcare of patients with endocrine diseases during transition from paediatric to adult care settings. Results: While a consensus was reached that a team approach is best, discussions revealed that a ‘one size fits all’ model for transition is largely unsuccessful in these patients. They need more tailored care during adolescence to prevent complications like failure to achieve target adult height, reduced bone mineral density, morbid obesity, metabolic perturbations (obesity and body composition), inappropriate/inadequate puberty, compromised fertility, diminished quality of life and failure to adapt to the demands of adult life. Sometimes it is difficult for young people to detach emotionally from their paediatric endocrinologist and/or the abrupt change from an environment of parental responsibility to one of autonomy. Discussions about impending transition and healthcare autonomy should begin in early adolescence and continue throughout young adulthood to ensure seamless continuum of care and optimal treatment outcomes. Conclusions: Even amongst a group of healthcare professionals with a great interest in improving transition services for patients with endocrine diseases, there is still much work to be done to improve the quality of healthcare for transition patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Current recommendations suggest retesting patients in the transition phase for GHD using GH stimulation tests when there is clinical suspicion of GHD and when serum IGF-I SDS is <0.76,117”
In the citing paper
“Emerging data continue to show that GH treatment can improve non–height-related parameters such as bone mass, body composition, and QOL, even after adult height has been reached.”
In the citing paper
“A lack of communication and coordination between pediatric and adult healthcare providers can result in inefficient treatment, patients being lost to follow-up as adults, or a large gap between the end of pediatric care and the beginning of adult care.117,123-125”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group
Bondy, C. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1374 · Cited by 1,005
Improving the transition between paediatric and adult healthcare: a systematic review
Crowley, R., Wolfe, I., Lock, K., & McKee, M. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2010.202473 · Cited by 649
Ho, K. K. Y., & _, _. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0631 · Cited by 615
Consensus statement on the management of the GH-treated adolescent in the transition to adult care
Clayton, P. E., Cuneo, R. C., Juul, A., Monson, J. P., Shalet, S. M., & Tauber, M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01829 · Cited by 270
Self-citationMeasuring the “triple aim” in transition care: a systematic review
Prior, M., McManus, M., White, P., & Davidson, L. (2014) · PEDIATRICS · doi:10.1542/peds.2014-1704 · Cited by 176
Hormone replacement therapy may improve hepatic function in women with Turner's syndrome
Elsheikh, M., Hodgson, H. J. F., Wass, J. A. H., & Conway, G. S. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01321.x · Cited by 109
Gleeson, H., Davis, J., Jones, J., O'Shea, E., & Clayton, P. E. (2013) · Clinical Endocrinology · doi:10.1111/cen.12053 · Cited by 103
Self-citationNocturnal hypertension and impaired sympathovagal tone in Turner syndrome
Gravholt, C. H., Hansen, K. W., Erlandsen, M., Ebbehøj, E., & Christiansen, J. S. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000200509.17947.0f · Cited by 90
Cited by
Yuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
Lin, A. E., Prakash, S. K., Andersen, N. H., Viuff, M. H., Levitsky, L. L., Rivera‐Davila, M., Crenshaw, M. L., Hansen, L., Colvin, M. K., Hayes, F. J., et al. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61310 · Cited by 50
New insights on diabetes in Turner syndrome: results from an observational study in adulthood
Ibarra-Gasparini, D., Altieri, P., Scarano, E., Perri, A., Morselli-Labate, A. M., Pagotto, U., Mazzanti, L., Pasquali, R., & Gambineri, A. (2018) · Endocrine · doi:10.1007/s12020-017-1336-z · Cited by 31
Wexler, T. L., Reifschneider, K., Backeljauw, P., Cárdenas, J. F., Hoffman, A. R., Miller, B. S., & Yuen, K. C. J. (2023) · Journal of Neurotrauma · doi:10.1089/neu.2022.0384 · Cited by 19
Deficient knowledge in adult Turner syndrome care as an incentive to found Turner centers in Germany
Kahlert, E., Blaschke, M., Brockmann, K., Freiberg, C., Janssen, O. E., Stahnke, N., Strik, D., Merkel, M., Mann, A., Liesenkötter, K.-P., et al. (2019) · Endocrine Connections · doi:10.1530/ec-19-0418 · Cited by 14
Metadata
- Authors
- Hokken-Koelega, A., van der Lely, A.-J., Hauffa, B., Häusler, G., Johannsson, G., Maghnie, M., Argente, J., DeSchepper, J., Gleeson, H., Gregory, J. W., Höybye, C., Keleştimur, F., Luger, A., Müller, H. L., Neggers, S., Popovic-Brkic, V., Porcu, E., Sävendahl, L., Shalet, S., Spiliotis, B., & Tauber, M.
- Venue
- Endocrine Connections
- Publisher
- Bioscientifica
- Published
- 2016-11
- Volume
- 5
- Issue
- 6
- Pages
- R44-R54
- ISSN
- 2049-3614
- Cited by
- 42
- References
- 8
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.